Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2025-12-29 @ 12:42 PM
Study NCT ID:
NCT06826950
Status:
COMPLETED
Last Update Posted:
2025-02-14
First Post:
2025-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Pharmacy Services on Gynaecology Chemotherapy Safety
Sponsor:
Peking University First Hospital
Organization:
Study Overview
Official Title:
The Impact of Comprehensive Pharmaceutical Services on Medication Safety in Gynaecological Oncology Chemotherapy Patients
Status:
COMPLETED
Status Verified Date:
2025-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
What was studied? We wanted to see whether having pharmacists closely involved in cancer care improves medication safety and reduces severe side effects for patients with gynecologic cancers (like ovarian or uterine cancer) during chemotherapy.
How was the study done?
Who participated? Patients receiving chemotherapy at Peking University First Hospital's Gynecologic Oncology Ward (September 2022-September 2024).
Two groups compared:
Standard care group: Pharmacists provided routine pharmaceutical services.
Full pharmacy care group: Pharmacists provided ongoing support, including:
Checking medications for safety.
Teaching patients how to manage side effects.
Answering questions about drugs.
Helping manage reactions like nausea or low white blood cells.
What was measured? Severe side effects (e.g., extreme nausea, appetite loss), how well doctors prescribed and monitored medications to boost white blood cells, and unplanned hospital stays.
Key findings:
Patients with full pharmacy care had:
Fewer severe side effects: Less extreme nausea, appetite loss, and dangerously low white blood cell counts.
Better management of blood cell-boosting medications: Doctors followed guidelines more closely, and patients received proper monitoring.
Fewer unplanned hospital visits: Likely due to better side effect prevention and early intervention.
Why does this matter?
For patients: Pharmacist support during chemotherapy may help you avoid severe side effects and reduce unexpected hospital stays.
For families: Knowing pharmacists are actively involved can provide reassurance about your loved one's medication safety.
For healthcare teams: Structured pharmacist collaboration improves adherence to treatment guidelines and patient outcomes.
Takeaway:
Full pharmacy care throughout chemotherapy helps protect patients' safety, reduces severe reactions, and supports smoother treatment journeys.
How was the study done?
Who participated? Patients receiving chemotherapy at Peking University First Hospital's Gynecologic Oncology Ward (September 2022-September 2024).
Two groups compared:
Standard care group: Pharmacists provided routine pharmaceutical services.
Full pharmacy care group: Pharmacists provided ongoing support, including:
Checking medications for safety.
Teaching patients how to manage side effects.
Answering questions about drugs.
Helping manage reactions like nausea or low white blood cells.
What was measured? Severe side effects (e.g., extreme nausea, appetite loss), how well doctors prescribed and monitored medications to boost white blood cells, and unplanned hospital stays.
Key findings:
Patients with full pharmacy care had:
Fewer severe side effects: Less extreme nausea, appetite loss, and dangerously low white blood cell counts.
Better management of blood cell-boosting medications: Doctors followed guidelines more closely, and patients received proper monitoring.
Fewer unplanned hospital visits: Likely due to better side effect prevention and early intervention.
Why does this matter?
For patients: Pharmacist support during chemotherapy may help you avoid severe side effects and reduce unexpected hospital stays.
For families: Knowing pharmacists are actively involved can provide reassurance about your loved one's medication safety.
For healthcare teams: Structured pharmacist collaboration improves adherence to treatment guidelines and patient outcomes.
Takeaway:
Full pharmacy care throughout chemotherapy helps protect patients' safety, reduces severe reactions, and supports smoother treatment journeys.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2024SF58 | OTHER_GRANT | Peking University First Hospital, China | View |